CORRECTION: BBS-Bioactive Bone Substitutes Plc: BBS arranges a rights offering of approximately maximum EUR 2.63 million

BBS-Bioactive Bone Substitutes Plc, Company Announcement, Insider information, 20 November 2023 at 18.29 p.m. EEST Correction: In the english stock exchange releases annex for terms and conditions of the offering “The custodian, account operator or nominee of the shareholder and/or investor shall receive the subscription order and the payment no later than on 23 December 2023 or at an earlier time according to the instructions given by the custodian, account operator or nominee.” was an incorrec

Related Keywords

Hong Kong ,South Africa ,Australia ,Netherlands ,New Zealand ,Japan ,Singapore ,Finland ,Canada ,United States ,Finnish ,Medtech Europe ,Juliusz Rakowski ,Bioactive Bone Substitutes Plc ,Medicines Agency ,Euroclear Finland Ltd ,Finnish Medicines Agency ,Bone Substitutes Plc ,Company Announcement ,Extraordinary General Meeting ,Subscription Rights ,Offer Shares ,Notified Body ,Medical Device Regulation ,Business Finland ,Medtech Europe Survey ,Euroclear Finland ,Subscription Right ,First North Growth Market Finland ,Temporary Shares ,First North Finland ,Trade Register ,Basic Information ,Investor Memorandum ,Basic Information Document ,Finnish Securities Markets Act ,Nasdaq First North Growth Market Finland ,Bbs ,The Company ,Bbs Bioactive Bone Substitutes Plc ,Rights Offering ,